- the details, where possible, of the antibiotic products these companies supply or have supplied.

Size: px
Start display at page:

Download "- the details, where possible, of the antibiotic products these companies supply or have supplied."

Transcription

1 Under the Freedom of Information Act 2000 please could you provide me with a list of all companies currently supplying antibiotics - or that have supplied antibiotics in the last three years - to Royal Surrey County Hospital NHS Foundation Trust. Plus: - the details, where possible, of the antibiotic products these companies supply or have supplied. Please find below a list of all companies that have supplied antibiotics in the last 3 years to the Royal Surrey County Hospital NHS Foundation Trust: Antibiotic AMIKACIN 50 mg in 1ml Injection 5 x 2ml Vial AMIKACIN 500 mg in 2ml Injection 5 x 2ml Vial AMOXICILLIN 125 mg in 5ml Suspension 100 ml AMOXICILLIN 125 mg in 5ml Suspension 100 ml TTO AMOXICILLIN 250 mg Capsules 15 Capsule AMOXICILLIN 250 mg Capsules 21 Capsule AMOXICILLIN 250 mg in 5ml Suspension 100 ml AMOXICILLIN 250 mg in 5ml Suspension 100 ml TTO AMOXICILLIN 250 mg Injection 10 Vial AMOXICILLIN 500 mg Capsules 15 Capsule TTO AMOXICILLIN 500 mg Capsules 21 Capsule AMOXICILLIN 500 mg Capsules 21 Capsule TTO AMOXICILLIN 500 mg Injection 10 Vial AMOXICILLIN SUGAR FREE 3 g Sachet 2 Sachet AZITHROMYCIN 200mg in 5 ml Suspension 15 ml AZITHROMYCIN 200mg in 5 ml Suspension 15 ml Overlabelled Pack AZITHROMYCIN 250 mg Capsules 4 Capsule AZITHROMYCIN 250 mg Tablets 4 Tablet AZTREONAM 1 g Injection 1 Vial AZTREONAM 2 g Injection 1 Vial BENZATHINE BENZYLPENICILLIN 2.4 million units Injection 1 Vial BENZYLPENICILLIN 600 mg Injection 25 Vial cefalexin 125 mg in 5ml Suspension 100 ml cefalexin 125 mg in 5ml Suspension 100 ml TTO Companies that have supplied the listed antibiotic in the last three years to Royal Surrey County Hospital NHS Foundation Trust Hospira ; Farnham ; Mawdsleys Brooks Overlabelling; ; ; ; Sigma; Mawdsleys Mawdsleys; ; ; Farnham ; ; Mawdsleys; ; ; ; Farnham ; Mawdsleys; ; Farnham ; ; ; ; ; Frimley Park Hospital ; ; Frimley Park Hospital UL Medicines; Durbin; Alium Medical Mawdsleys; ; ; Alloga Farnham

2 cefalexin 250 mg Capsules 28 Capsule cefalexin 250 mg in 5ml Suspension 100 ml cefalexin 250 mg in 5ml Suspension 100 ml TTO cefalexin 500 mg Capsules 21 Capsule cefalexin 500 mg Capsules 21 Capsule TTO cefixime 200 mg Tablets 7 Tablet cefotaxime 1 g Injection 1 Vial cefotaxime 1 g Injection 10 Vial cefotaxime 2 g Injection 1 Vial cefotaxime 2 g Injection 10 Vial cefotaxime 500 mg Injection 1 Vial cefotaxime 500 mg Injection 10 Vial cefradine 250 mg Capsules 20 Capsule ceftazidime 1 g Injection 1 Vial ceftazidime 1 g Injection 5 Vial ceftazidime 2 g Injection 1 Vial ceftazidime 2 g Injection 5 Vial ceftriaxone 1 g Injection 1 Vial ceftriaxone 1 g Injection 5 Vial ceftriaxone 2 g Injection 2 g Vial ceftriaxone 250 mg Injection 1 Vial cefuroxime 1.5 g Injection 1 Vial cefuroxime 1.5 g Injection 10 Vial cefuroxime 250 mg Injection 1 Vial cefuroxime 750 mg Injection 1 Vial cefuroxime 750 mg Injection 10 Vial cefuroxime 750 mg Injection 5 Vial Pack CHLORAMPHENICOL 1 g Injection 1 g Vial CIPROFLOXACIN 200 mg in 100ml Intravenous Infusion 1 x 100ml Vial CIPROFLOXACIN 200 mg in 100ml Intravenous Infusion 10 x 100ml Vial Pack CIPROFLOXACIN 250 mg in 5ml Suspension 100 ml with Diluent CIPROFLOXACIN 250 mg Tablets 20 Tablet CIPROFLOXACIN 400mg in 200ml Intravenous Infusion 1 x 200ml Vial CIPROFLOXACIN 400mg in 200ml Intravenous Infusion 10 x 200ml Vial Pack CIPROFLOXACIN 500 mg Tablets 10 Tablet CIPROFLOXACIN 500 mg Tablets 10 Tablet TTO CIPROFLOXACIN 500 mg Tablets 3 Tablet TTO ; ; Alloga ; Alloga Farnham ; ; Alloga Farnham ; Mawdsleys Brooks Overlabelling ; Mawdsleys; ; TPS; ; ; TPS ; ; Mawdsleys; Aliance Mawdsleys; ; Mawdsleys; TPS; Mawdsleys; ; TPS; ; Oxford Pharmacy Stores; Mawdsleys; TPS; Alloga Mawdsleys; Oxford Pharmacy Stores Mawdsleys; Oxford Pharmacy Stores; ; ; Mawdsleys; ; Fresenius Kabi Mawdsleys; ; ; Farnham

3 CIPROFLOXACIN 500 mg Tablets 6 Tablet TTO CLARITHROMYCIN 125 mg in 5ml Suspension 100 ml CLARITHROMYCIN 125 mg in 5ml Suspension 70 ml CLARITHROMYCIN 125 mg in 5ml Suspension 70 ml Overlabelled Pack CLARITHROMYCIN 250 mg in 5ml Suspension 70 ml CLARITHROMYCIN 250 mg in 5ml Suspension 70 ml Overlabelled Pack CLARITHROMYCIN 250 mg Tablets 14 Tablet CLARITHROMYCIN 250 mg Tablets 14 Tablet TTO Farnham Mawdsleys; ; ; ; Mawdsleys; Ranbaxy; Farnham CLARITHROMYCIN 500 mg Injection 1 Vial CLARITHROMYCIN 500 mg Tablets 14 Tablet Mawdsleys; Ranbaxy; CLARITHROMYCIN 500 mg Tablets 14 Tablet TTO CLINDAMYCIN 150 mg Capsules 100 Capsule Mawdsleys CLINDAMYCIN 150 mg Capsules 24 Capsule Mawdsleys; CLINDAMYCIN 150 mg Capsules 56 Capsule Pre Farnham CLINDAMYCIN 300 mg in 2ml Injection 5 x 2ml Ampoule Focus; ; CLINDAMYCIN 600 mg in 4ml Injection 5 x 4ml Ampoule Focus; ; CLINDAMYCIN 75 mg Capsules 24 Capsule CLINDAMYCIN 75 mg in 5ml Paediatric Suspension 80 ml IDIS; Alium CO-AMOXICLAV 1.2 g Injection 10 Vial CO-AMOXICLAV 375 mg Tablets 21 Tablet CO-AMOXICLAV 375 mg Tablets 21 Tablet TTO CO-AMOXICLAV 625 mg Tablets 21 Tablet CO-AMOXICLAV 625 mg Tablets 21 Tablet TTO CO-AMOXICLAV SUGAR FREE 125/31 mg in 5ml CO-AMOXICLAV SUGAR FREE 125/31 mg in 5ml Suspension 100 ml TTO CO-AMOXICLAV SUGAR FREE 250/62.5mg in 5ml CO-AMOXICLAV SUGAR FREE 250/62.5mg in 5ml Suspension 100 ml TTO COLISTIMETHATE SODIUM (COLOMYCIN) (for Inhalation/Injection) 1 million units Injection 10 Vial COLISTIMETHATE SODIUM (COLOMYCIN) (for Inhalation/Injection) 2 million units Injection 10 Vial Mawdsleys; ; Mawdsleys; ; Farnham Mawdsleys; ; Mawdsleys; ; ; Movianto; ; ;

4 CO-TRIMOXAZOLE (UNLICENSED) 480 mg in 5ml Intravenous Infusion 5 x 5ml Ampoule Pack CO-TRIMOXAZOLE 240 mg in 5ml Paediatric CO-TRIMOXAZOLE 480 mg in 5ml Intravenous Infusion 10 x 5ml Ampoule CO-TRIMOXAZOLE 480 mg in 5ml Suspension 100 ml CO-TRIMOXAZOLE 480 mg Tablets 100 Tablet CO-TRIMOXAZOLE 480 mg Tablets 28 Tablet DAPSONE 100 mg Tablets 28 Tablet DAPSONE 50 mg Tablets 28 Tablet DAPTOMYCIN 350 mg Injection 1 Vial DAPTOMYCIN 500 mg Injection 1 Vial DOXYCYCLINE (TTO Pack) 100 mg Capsules 14 Capsule DOXYCYCLINE 100 mg Capsules 50 Capsule DOXYCYCLINE 100 mg Dispersible Tablets 8 Tablet DOXYCYCLINE 50 mg Capsules 28 Capsule Pack ERTAPENEM 1 g Injection 1 Vial Oxford Pharmacy Stores Royal Marsden Hospital; Movianto; Frimley Park Hospital ; Sigma; ; ; ; Farnham ; ; ; ; ERYTHROMYCIN 1 g Injection 1 Vial ERYTHROMYCIN 250 mg Enteric Coated Tablets 28 Tablet ERYTHROMYCIN 250 mg Enteric Coated Tablets 28 Tablet Overlabelled Pack ERYTHROMYCIN SUGAR FREE 125 mg in 5ml ERYTHROMYCIN SUGAR FREE 125 mg in 5ml Suspension 100 ml TTO ERYTHROMYCIN SUGAR FREE 250 mg in 5ml ERYTHROMYCIN SUGAR FREE 250 mg in 5ml Suspension 100 ml TTO ETHAMBUTOL HYDROCHLORIDE 100 mg Tablets 56 Tablet ; ; ETHAMBUTOL HYDROCHLORIDE 400 mg Tablets 56 Tablet ; FLUCLOXACILLIN 1 g Injection 10 Vial FLUCLOXACILLIN 125 mg in 5ml Syrup 100 ml FLUCLOXACILLIN 125 mg in 5ml Syrup 100 ml TTO FLUCLOXACILLIN 250 mg Capsules 28 Capsule FLUCLOXACILLIN 250 mg Capsules 28 Capsule TTO FLUCLOXACILLIN 250 mg in 5ml Syrup 100 ml FLUCLOXACILLIN 250 mg in 5ml Syrup 100 ml TTO FLUCLOXACILLIN 250 mg Injection 10 Vial Mawdsleys; ; ; ; Mawdsleys; Sigma Sigma; Alloga ; Sigma; ; ;

5 FLUCLOXACILLIN 500 mg Capsules 28 Capsule FLUCLOXACILLIN 500 mg Capsules 28 Capsule TTO FLUCLOXACILLIN 500 mg Injection 10 Vial FOSFOMYCIN 3 g Oral Powder 3 g Sachet GENTAMICIN 20 mg in 2ml Injection 5 Vial GENTAMICIN 80 mg in 2ml Injection 10 x 2ml Vial GENTAMICIN 80 mg in 2ml Injection 5 x 2ml Vial IMIPENEM (WITH CILASTATIN) (PRIMAXIN) 500 mg Intravenous Injection 20 ml Vial IMIPENEM 500mg AND CILASTATIN 500mg Injection 10 x 20ml Vial Pack ISONIAZID 100 mg Tablets 28 Tablet ISONIAZID 50 mg in 5ml Syrup 500 ml LEVOFLOXACIN (BOTTLE) 5 mg in 1ml Intravenous Infusion 10 x 100ml Pack LEVOFLOXACIN 250 mg Tablets 10 Tablet LEVOFLOXACIN 250 mg Tablets 5 Tablet Pack LINEZOLID 100 mg in 5ml Suspension 150 ml Pack LINEZOLID 600 mg Injection 1 INFUSION Bag LINEZOLID 600 mg Injection 10 INFUSION Pack LINEZOLID 600 mg Tablets 10 Tablet LYMECYCLINE 408 mg Capsules 28 Capsule MEROPENEM 1 g Injection 10 Vial MEROPENEM 500 mg Injection 10 Vial METRONIDAZOLE 1 g Suppositories 10 Suppository METRONIDAZOLE 200 mg in 5ml Suspension 100 ml METRONIDAZOLE 200 mg in 5ml Suspension 100 ml TTO METRONIDAZOLE 200 mg Tablets 21 Tablet METRONIDAZOLE 200 mg Tablets 21 Tablet Alloga ; ; Mawdsleys; Alium Mawdsleys; ; ; Ashford & St Peters Hospital Rosemont Fresenius Kabi Mawdsleys; ; Mawdsleys; Mawdsleys; ; Mawdsleys; Hospira; Fresenius Kabi ; ; Hospira Rosemont Farnham Sigma; METRONIDAZOLE 400 mg Tablets 14 Tablet Farnham Mawdley Brooks Overlabelling; Farnham METRONIDAZOLE 400 mg Tablets 21 Tablet METRONIDAZOLE 400 mg Tablets 21 Tablet Sigma; METRONIDAZOLE 500 mg in 100ml Intravenous Infusion 50 x 100ml Bag FE3400 Baxter METRONIDAZOLE 500 mg Suppositories 10 Suppository MINOCYCLINE 100 mg Modified Release Capsules 56 Capsule MINOCYCLINE 100 mg Tablets 28 Tablet MOXIFLOXACIN 400 mg Tablets 5 Tablet Mawdsleys;

6 MOXIFLOXACIN 400 mg Tablets 5 Tablet TTO NITROFURANTOIN 100 mg Capsules 30 Capsule NITROFURANTOIN 100 mg Tablets 28 Tablet Pack NITROFURANTOIN 25 mg in 5ml Suspension 300 ml NITROFURANTOIN 50 mg Capsules 30 Capsule NITROFURANTOIN 50 mg Capsules 30 Capsule Overlabelled Pack OFLOXACIN 200 mg Tablets 10 Tablet OFLOXACIN 200 mg Tablets 14 Tablet Pre- OFLOXACIN 400 mg Tablets 5 Tablet OXYTETRACYCLINE 250 mg Tablets 28 Tablet PHENOXYMETHYLPENICILLIN 125 mg in 5ml Syrup 100 ml PHENOXYMETHYLPENICILLIN 125 mg in 5ml Syrup 100 ml TTO PHENOXYMETHYLPENICILLIN 250 mg in 5ml Syrup 100 ml PHENOXYMETHYLPENICILLIN 250 mg in 5ml Syrup 100 ml TTO PHENOXYMETHYLPENICILLIN 250 mg Tablets 28 Tablet PHENOXYMETHYLPENICILLIN 250 mg Tablets 28 Tablet Overlabelled Pack PIPERACILLIN 2g and TAZOBACTAM 250mg Injection 1 Vial PIPERACILLIN 2g and TAZOBACTAM 250mg Injection 10 Vial PIPERACILLIN 4g and TAZOBACTAM 500mg Injection 1 Vial Pack PYRAZINAMIDE 500 mg Tablets 50 Tablet RIFABUTIN 150 mg Capsules 30 Capsule RIFAMPICIN 100 mg in 5ml Syrup 120 ml RIFAMPICIN 150 mg Capsules 100 Capsule RIFAMPICIN 150MG AND ISONIAZID 100MG Tablets 84 Tablet RIFAMPICIN 300 mg Capsules 100 Capsule RIFAMPICIN 300MG AND ISONIAZID 150MG Tablets 56 Tablet RIFAMPICIN 600 mg Intravenous Infusion 1 Vial with Solvent RIFATER Tablets 100 Tablet RIFAXIMIN (TARGAXAN) 550 mg Tablets 56 Tablet SODIUM FUSIDATE 250 mg Tablets 100 Tablet SULFADIAZINE 500 mg Tablets 56 Tablet TEICOPLANIN 200 mg Injection 1 Vial with Diluent TEICOPLANIN 400 mg Injection 1 Vial with Diluent Mawdsleys; ; Farnham ; ; Farnham Mawdsleys; ; Movianto; Mawdsleys; ; Mawdsleys Mawdsleys; Mawdsleys; ; Mawdsleys; ; IDIS; ; ; ; ; East Surrey Hospital; DHL Supply Chain Norgine; ; ;

7 TEMOCILLIN 1 g Injection 1 Vial TETRACYCLINE 250 mg Tablets 28 Tablet TIGECYCLINE 50 mg in 5ml Injection 10 Vial TINIDAZOLE 500 mg Tablets 16 Tablet Pack TOBRAMYCIN 300 mg in 4ml Nebuliser Solution 56 Ampoule TOBRAMYCIN 80 mg in 2ml Injection 1 Vial Pack TOBRAMYCIN 80 mg in 2ml Injection 10 Vial TRIMETHOPRIM 100 mg Tablets 28 Tablet TRIMETHOPRIM 200 mg Tablets 14 Tablet TRIMETHOPRIM 200 mg Tablets 14 Tablet TTO TRIMETHOPRIM SUGAR FREE 50 mg in 5ml TRIMETHOPRIM SUGAR FREE 50 mg in 5ml Suspension 100 ml TTO VANCOMYCIN 1 g Powder for Infusion 1 Vial VANCOMYCIN 125 mg Capsules 28 Capsule VANCOMYCIN 500 mg Powder for Infusion 1 Vial VANCOMYCIN 500 mg Powder for Infusion 10 Vial Pack Eumedica ; Frimley Park Hospital Alloga Mawdsleys; ; Mawdsleys; ; Mawdsleys; Sigma ; ; Alloga ; ; ; Alloga ; Alloga

I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics.

I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics. Ref: FOI/CAD/ID 3459 27 June 2017 Please reply to: FOI Administrator Trust Management Maidstone Hospital Hermitage Lane Maidstone Kent ME16 9QQ Email: mtw-tr.foiadmin@nhs.net Freedom of Information Act

More information

Freedom of Information Act 2000 Request Reference FoI/16/226 Companies Supplying Antibiotics

Freedom of Information Act 2000 Request Reference FoI/16/226 Companies Supplying Antibiotics Freedom of Information Act 2000 Request Reference FoI/16/226 Companies Supplying Antibiotics Request details Under the Freedom of Information Act 2000 please could you provide me with the following: 1.

More information

EUCAST recommended strains for internal quality control

EUCAST recommended strains for internal quality control EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC

More information

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review (1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of

More information

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018 Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?

More information

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Routine internal quality control as recommended by EUCAST Version 3.1, valid from Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus

More information

Introduction. Antimicrobial Usage ESPAUR 2014 Previous data validation Quality Premiums Draft tool CDDFT Experience.

Introduction. Antimicrobial Usage ESPAUR 2014 Previous data validation Quality Premiums Draft tool CDDFT Experience. Secondary Care Data Validation: What do commissioners need to know? Stuart Brown Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England March 2014 Introduction Antimicrobial

More information

AMR Industry Alliance Antibiotic Discharge Targets

AMR Industry Alliance Antibiotic Discharge Targets AMR Industry Alliance Antibiotic Discharge Targets List of Predicted No-Effect Concentrations (PNECs) The members of the AMR Industry Alliance have developed a unified approach to establishing discharge

More information

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Compliance of manufacturers of AST materials and devices with EUCAST guidelines Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The

More information

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The

More information

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to

More information

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Compliance of manufacturers of AST materials and devices with EUCAST guidelines Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The

More information

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01

More information

Report on the Point Prevalence Survey of Antimicrobial Prescribing in Secondary Care in Wales November/December 2009

Report on the Point Prevalence Survey of Antimicrobial Prescribing in Secondary Care in Wales November/December 2009 Report on the Point Prevalence Survey of Antimicrobial Prescribing in Secondary Care in Wales November/December 2009 Authors: Maggie Heginbothom Robin Howe Version: 1 Antimicrobial PPS - Wales Date: 26/04/2010

More information

EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia

EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia Background The Expert Advisory Group on Antimicrobial Resistance of the NH&MRC provides advice to Australian governments and

More information

Rate In Rs.Ps (ED Included. Tax Extra) Sl No Name Of The Product Pack. Scheduled And Non-Scheduled Formulations Capsules

Rate In Rs.Ps (ED Included. Tax Extra) Sl No Name Of The Product Pack. Scheduled And Non-Scheduled Formulations Capsules KAPL list of products applicable for Institutional/Hospital supplies under Pharmaceuticals Purchase Policy (PPP) issued by Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India

More information

What s new in EUCAST methods?

What s new in EUCAST methods? What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests

More information

PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS

PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS The current supply of piperacillin- tazobactam should be reserved f Microbiology / Infectious Diseases approval and f neutropenic sepsis, severe sepsis

More information

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix O 3 December 2014 Final version Commissioned

More information

2015 Antibiotic Susceptibility Report

2015 Antibiotic Susceptibility Report Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens

More information

PRODUCTS LIST INFECTIOLOGY

PRODUCTS LIST INFECTIOLOGY PRODUCTS LIST THERAPEUTIC CLASS REF. PRODUCT DESIGNATION CONDITIONNING 1ACIC200 Aciclovir 200mg 500 tabs 2ACIC200 Aciclovir 200mg 500 tabs blister 1ACIC400 Aciclovir 400mg 500 tabs 2ACIC400 Aciclovir 400mg

More information

Intro Who should read this document 2 Key practice points 2 Background 2

Intro Who should read this document 2 Key practice points 2 Background 2 Antibiotic Guidelines: Obstetric Anti-Infective Prescribing Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Kelly Alexander / Frances Garraghan

More information

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ... SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* The next-generation MicroScan WalkAway System combines proven technology and reliability with enhanced ease-of-use features to streamline

More information

2016 Antibiotic Susceptibility Report

2016 Antibiotic Susceptibility Report Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates

More information

British Society for Antimicrobial Chemotherapy

British Society for Antimicrobial Chemotherapy British Society for Antimicrobial Chemotherapy BSAC to actively support the EUCAST Disc Diffusion Method for Antimicrobial Susceptibility Testing in preference to the current BSAC Disc Diffusion Method

More information

3 party manufacturing PRODUCT LIST. Category : ANTI BIOTIC

3 party manufacturing PRODUCT LIST. Category : ANTI BIOTIC rd 3 party manufacturing PRODUCT LIST Category : ANTI BIOTIC ANTI BIOTIC SR.NO. COMPOSTION DRUG/FOOD DOSAGE PACKING 1 Amikacin Sulphate IP 500mg/2ml DRUG LIQUID INJ. VIAL 2 Amoxicillin 200mg & Clavulanic

More information

British Society for Antimicrobial Chemotherapy

British Society for Antimicrobial Chemotherapy British Society for Antimicrobial Chemotherapy Standing Committee on Susceptibility Testing Version 13.0, 10-06-2014 Content Page Additional information Changes in version 13 2 Suggestions for appropriate

More information

MEDICATIONS MEXICO S DE R.L. DE C.V. Agrifen Acetaminophen Chlorpheniramine 40 # Amikacin Generic 500 mg 2ml 2 ampoules #

MEDICATIONS MEXICO S DE R.L. DE C.V. Agrifen Acetaminophen Chlorpheniramine 40 # Amikacin Generic 500 mg 2ml 2 ampoules # Agrifen Acetaminophen Chlorpheniramine 40 $10 tabs Amikacin Generic 500 mg 2ml 2 ampoules $11 inyectable Amoxil Amoxicillin 500 mg 12 Caps $20 Amoxil Amoxicillin Generic 500 mg 12 Caps $13 Amoxil Amoxicillin

More information

Antimicrobial Susceptibility Testing: Advanced Course

Antimicrobial Susceptibility Testing: Advanced Course Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to

More information

ANTIBIOTICS. Orbit s ANTIBIOTICS. Portfolio

ANTIBIOTICS. Orbit s ANTIBIOTICS. Portfolio ANTIBIOTICS Orbit s ANTIBIOTICS Portfolio ANTIBIOTICS Antibiotics (from ancient Greek αντιβιοτικά, antibiotiká), also called antibacterials, are a type of antimicrobial drug used in the treatment and prevention

More information

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2. AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony

More information

ANTIBIOTIC FORMULARY AND PRESCRIBING ADVICE FOR PAEDIATRIC PATIENTS OTHER THAN NEONATES

ANTIBIOTIC FORMULARY AND PRESCRIBING ADVICE FOR PAEDIATRIC PATIENTS OTHER THAN NEONATES ANTIBIOTIC FORMULARY AND PRESCRIBING ADVICE FOR PAEDIATRIC PATIENTS OTHER THAN NEONATES VERSION 1.2 EFFECTIVE 01 APRIL 2015 THIS DOCUMENT SUPERSEDES ALL ANTIBIOTIC GUIDANCE FROM ANY SOURCE REGARDING PAEDIATRIC

More information

OPAT discharge navigator and laboratory monitoring Select OPAT button for ALL patients that discharge on intravenous antimicrobials

OPAT discharge navigator and laboratory monitoring Select OPAT button for ALL patients that discharge on intravenous antimicrobials Clinical Monitoring of Outpatient Parenteral Antimicrobial Therapy (OPAT) and Selected Oral Antimicrobial Agents Adult Inpatient/Ambulatory Clinical Practice Guideline Appendix A. Coordinating an OPAT

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #116 (NQF 0058): Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton

More information

Antimicrobial Susceptibility Testing: The Basics

Antimicrobial Susceptibility Testing: The Basics Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories

More information

Antibiotic Usage Guidelines in Hospital

Antibiotic Usage Guidelines in Hospital SUPPLEMENT TO JAPI december VOL. 58 51 Antibiotic Usage Guidelines in Hospital Camilla Rodrigues * Use of surveillance data information of Hospital antibiotic policy guidelines from Hinduja Hospital. The

More information

QUALITY HEALTH CARE YOUR PREFERRED PARTNER IN. For better health

QUALITY HEALTH CARE YOUR PREFERRED PARTNER IN. For better health YOUR PREFERRED PARTNER IN QUALITY HEALTH CARE For better health Manufacturer of Pharmaceutical Products Eka Pharma 308, Samanvay Zillion, Gotri - Sevasi Road, Opp. Shaishav School, Vadodara-391 101, (Guj.)

More information

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016 Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate

More information

Antibiotic guideline in Adult Cystic Fibrosis

Antibiotic guideline in Adult Cystic Fibrosis Antibiotic guideline in Adult Cystic Fibrosis Choice of antibiotics in cystic fibrosis is based on several facts including ganism sensitivity, histy of adverse reactions allergy and severity of symptoms.

More information

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents Journal of Antimicrobial Chemotherapy (5) 35, -5 Brief reports Heat stability of the antimicrobial activity of sixty-two antibacterial agents Walter H. Traub and Birgit Leonhard Institut fur Medizinische

More information

Antimicrobial susceptibility

Antimicrobial susceptibility Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL

More information

BSAC standardized disc susceptibility testing method (version 8)

BSAC standardized disc susceptibility testing method (version 8) Journal of Antimicrobial Chemotherapy (2009) 64, 454 489 doi:10.1093/jac/dkp244 Advance Access publication 8 July 2009 BSAC standardized disc susceptibility testing method (version 8) J. M. Andrews* for

More information

Pharmaceutical issues relating to STI s. June Minton Lead HIV/GUM & Infectious Diseases Pharmacist University College London Hospitals NHS Trust

Pharmaceutical issues relating to STI s. June Minton Lead HIV/GUM & Infectious Diseases Pharmacist University College London Hospitals NHS Trust Pharmaceutical issues relating to STI s June Minton Lead HIV/GUM & Infectious Diseases Pharmacist University College London Hospitals NHS Trust Objectives Treatment options for syphilis, LGV, TV, gonorrhoea

More information

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient 1 Chapter 79, Self-Assessment Questions 1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient with normal renal function is: A. Trimethoprim-sulfamethoxazole B. Cefuroxime

More information

Antibiotic guideline in Adult Cystic Fibrosis

Antibiotic guideline in Adult Cystic Fibrosis Antibiotic guideline in Adult Cystic Fibrosis Choice of antibiotics in cystic fibrosis is based on several facts including ganism sensitivity, histy of adverse reactions allergy and severity of symptoms.

More information

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how? Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how? Andrea Duppenthaler andrea.duppenthaler@insel.ch Limping patient local pain swelling tenderness warmth fever acute Osteomyelitis

More information

Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland,

Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland, Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland, 2008-2016 Alicia Russell Federation of Infection Societies conference 14 th November 2018 alisia_russell BSAC

More information

Report on Point Prevalence Survey of Antibacterial Prescribing at Ysbyty Gwynedd Hospital November 2008

Report on Point Prevalence Survey of Antibacterial Prescribing at Ysbyty Gwynedd Hospital November 2008 Report on Point Prevalence Survey of Antibacterial Prescribing at Ysbyty Gwynedd Hospital November 2008 Authors: Maggie Heginbothom Robin Howe Version: 1 Antibacterial PPS Ysbyty Gwynedd Date: 29/05/2009

More information

Section 6.2 Antibacterials including Access, Watch and Reserve Lists of antibiotics

Section 6.2 Antibacterials including Access, Watch and Reserve Lists of antibiotics Consideration of antibacterial medicines as part of the revisions to 2017 WHO Model List of Essential Medicines for adults (EML) and Model List of Essential Medicines for children (EMLc) Section 6.2 Antibacterials

More information

Should we test Clostridium difficile for antimicrobial resistance? by author

Should we test Clostridium difficile for antimicrobial resistance? by author Should we test Clostridium difficile for antimicrobial resistance? Paola Mastrantonio Department of Infectious Diseases Istituto Superiore di Sanità, Rome,Italy Clostridium difficile infection (CDI) (first

More information

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه

More information

Volume 1; Number 7 November 2007

Volume 1; Number 7 November 2007 Volume 1; Number 7 November 2007 CONTENTS Page 1 Page 3 Guidance on the Use of Antibacterial Drugs in Lincolnshire Primary Care: Winter 2007/8 NICE Clinical Guideline 54: Urinary Tract Infection in Children

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton

More information

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups Gunnar Kahlmeter, Derek Brown Izmir, February 2011 Anaerobes subcommittee EUCAST Subcommittee on breakpoints

More information

GENERAL NOTES: 2016 site of infection type of organism location of the patient

GENERAL NOTES: 2016 site of infection type of organism location of the patient GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered

More information

INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT

INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT Name & Title Of Authors: Dr M Milupi, Consultant Microbiologist Dr N Rao,Consultant Paediatrician Dr V Desai Consultant Paediatrician Date Revised: APRIL

More information

Measuring Antibiotic Use in NHSN

Measuring Antibiotic Use in NHSN Measuring Antibiotic Use in NHSN Jonathan R. Edwards, MStat. Research Mathematical Statistician Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases SHEA

More information

Between 5% and 10% of patients admitted to hospitals acquire one or more infections, based on reporting data largely from developed countries.

Between 5% and 10% of patients admitted to hospitals acquire one or more infections, based on reporting data largely from developed countries. Between 5% and 10% of patients admitted to hospitals acquire one or more infections, based on reporting data largely from developed countries. In the USA, it is reported that 1 out of every 136 hospital

More information

GOBIERNO DE PUERTO RICO Administración de Servicios Médicos de Puerto Rico

GOBIERNO DE PUERTO RICO Administración de Servicios Médicos de Puerto Rico 1 Acetylcysteine Solution 20% Vial 10ml 2 Acetylcysteine Solution 20% Vial 30ml 3 Activated Charcoal Bottle 4 fl oz or 8 fl oz 4 Adenosine 6mg/2ml Inj Solution Syringe / Vial 2ml 5 Albuterol Sulfate Inhalation

More information

* gender factor (male=1, female=0.85)

* gender factor (male=1, female=0.85) Usual Doses of Antimicrobials Typically Not Requiring Renal Adjustment Azithromycin 250 500 mg Q24 *Amphotericin B 1 3-5 mg/kg Q24 Clindamycin 600 900 mg Q8 Liposomal (Ambisome ) Doxycycline 100 mg Q12

More information

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical

More information

Treating Multi-drug Resistant Gramnegative. Fiona Robb Antimicrobial Pharmacist NHS Greater Glasgow & Clyde 9 th December 2016

Treating Multi-drug Resistant Gramnegative. Fiona Robb Antimicrobial Pharmacist NHS Greater Glasgow & Clyde 9 th December 2016 Treating Multi-drug Resistant Gramnegative Infections in OPAT Fiona Robb Antimicrobial Pharmacist NHS Greater Glasgow & Clyde 9 th December 2016 Overview To describe the emerging threat of Antimicrobial

More information

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

56 Clinical and Laboratory Standards Institute. All rights reserved.

56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:

More information

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California

More information

Quality of 2 nd line medicines for tuberculosis. Ms Lisa Hedman World Health Organization Department of Essential Medicines and Health Products

Quality of 2 nd line medicines for tuberculosis. Ms Lisa Hedman World Health Organization Department of Essential Medicines and Health Products Quality of 2 nd line medicines for tuberculosis Ms Lisa Hedman World Health Organization Department of Essential Medicines and Health Products Case studies in medicines for tuberculosis Outline: Statistics

More information

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,

More information

Antimicrobial Susceptibility Patterns

Antimicrobial Susceptibility Patterns Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department

More information

GUIDELINES FOR USERS ANTIMICROBIAL REFERENCE LABORATORY ANTIMICROBIAL ASSAY SERVICE. 18th Edition

GUIDELINES FOR USERS ANTIMICROBIAL REFERENCE LABORATORY ANTIMICROBIAL ASSAY SERVICE. 18th Edition ANTIMICROBIAL REFERENCE LABORATORY ANTIMICROBIAL ASSAY SERVICE GUIDELINES FOR USERS 18th Edition 2015 Earlier editions should be destroyed Antimicrobial Reference Laboratory Department of Medical Microbiology

More information

Guidelines for Antimicrobial treatment for treatment of confirmed infections adults

Guidelines for Antimicrobial treatment for treatment of confirmed infections adults Guidelines for Antimicrobial treatment for treatment of confirmed infections adults This guideline gives recommendations for treatment of confirmed infections in adults for children please see the Paediatric

More information

POINT PREVALENCE SURVEY A tool for antibiotic stewardship in hospitals. Koen Magerman Working group Hospital Medicine

POINT PREVALENCE SURVEY A tool for antibiotic stewardship in hospitals. Koen Magerman Working group Hospital Medicine POINT PREVALENCE SURVEY A tool for antibiotic stewardship in hospitals Koen Magerman Working group Hospital Medicine Background Strategic plan By means of a point prevalence survey and internal audits

More information

Penicillins - EUCAST clinical MIC breakpoints (version 1.3)

Penicillins - EUCAST clinical MIC breakpoints (version 1.3) EUCAST clinical MIC breakpoints - penicillins Penicillins - EUCAST clinical MIC breakpoints 2009-04-19 (version 1.3) Penicillins Click on antibiotic name to see wild type MIC distributions. Enterobacteriaceae

More information

50mg per 1000 tablets. 300mg per 1000 tablets. 100mg/ml 10ml per 100 amps. 200mg per 1000 tablets 400mg per 1000 tablets. 500mg per 1000 tablets

50mg per 1000 tablets. 300mg per 1000 tablets. 100mg/ml 10ml per 100 amps. 200mg per 1000 tablets 400mg per 1000 tablets. 500mg per 1000 tablets info@diagimaging.com DIAGNOSTIC IMAGING LTD Elkington Lodge, Welford, Northants NN6 6HE UK T el +44 (0)845 226 0520 Fax +44 (0)845 226 0521 Acetazolamide Adrenaline injection 1mg/ml Albendazole Albendazole

More information

Intrinsic, implied and default resistance

Intrinsic, implied and default resistance Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been

More information

Surveillance of Antimicrobial Use and Resistance in Northern Ireland, Annual Report, 2017

Surveillance of Antimicrobial Use and Resistance in Northern Ireland, Annual Report, 2017 Surveillance of Antimicrobial Use and Resistance in Northern Ireland, Annual Report, 2017 CONTENTS Contents Executive summary 3 Background 5 Method 7 Antibiotic resistance..................................

More information

EUCAST-and CLSI potency NEO-SENSITABS

EUCAST-and CLSI potency NEO-SENSITABS EUCASTand CLSI potency NEOSENSITABS Neo Sensitabs Page 1 / 6 Document: 6.2.0 Fastidious organisms EUCAST Interpretation zones and MIC breakpoints according to recommendations by the "Comité de l'antibiogramme

More information

Discussion Points. Decisions in Selecting Antibiotics

Discussion Points. Decisions in Selecting Antibiotics Antibiotics in Acute Care Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical

More information

INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT

INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT Name & Title Of Authors: Dr M Milupi, Consultant Microbiologist Dr N Rao,Consultant Paediatrician Dr V Desai Consultant Paediatrician Date Revised: DEC 2015

More information

Studies on Antimicrobial Consumption in a Tertiary Care Private Hospital, India

Studies on Antimicrobial Consumption in a Tertiary Care Private Hospital, India Human Journals Research Article April 2016 Vol.:6, Issue:1 All rights are reserved by Zarine Khety et al. Studies on Antimicrobial Consumption in a Tertiary Care Private Hospital, India Keywords: Drug

More information

Antibiotic Updates: Part II

Antibiotic Updates: Part II Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures

More information

MicroScan Microbiology Systems MORE CHOICES MORE ANSWERS. MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS

MicroScan Microbiology Systems MORE CHOICES MORE ANSWERS. MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS MicroScan Microbiology Systems MORE CHOICES MORE ANSWERS MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS LABORATORIES ON THE FRONT LINE From the National Action Plan for Combating Antibiotic Resistant

More information

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services 2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens

More information

Antibacterial Resistance In Wales

Antibacterial Resistance In Wales A Report from Public Health Wales Antimicrobial Resistance Programme Surveillance Unit: Antibacterial Resistance In Wales 2005-2013 Authors: Maggie Heginbothom and Robin Howe Version: 1 Antibacterial Resistance

More information

CONCORD DRUGS LIMITED Hyderabad

CONCORD DRUGS LIMITED Hyderabad CONCORD DRUGS LIMITED Hyderabad Product List (Injectables) Tissue Bio Adhesive Product Name Packing Strength/ Each Ampoule Therapeutic use Iso Amyl 2-Cyano Acrylate Ampoule 0.25, 0.50 and 1.0 ml. Bio-Adhesive

More information

Lyme disease: diagnosis and management

Lyme disease: diagnosis and management National Institute for Health and Care Excellence Final Lyme disease: diagnosis and management [D] Evidence review for the management of erythema migrans NICE guideline 95 Evidence review April 2018 Final

More information

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information

More information

ENSURING ACCESS TO OLD ANTIBIOTICS

ENSURING ACCESS TO OLD ANTIBIOTICS ENSURING ACCESS TO OLD ANTIBIOTICS Bojana Beovic 1, Guillaume Béraud 1,2, Jean Carlet 2, Otto Cars 3, Philip Howard 1, Gabriel Levy-Hara 4, Grace Li, Dilip Nathwani 5, France Roblot 6 On behalf of the

More information

BIO4 Antibiotics Expert Committee

BIO4 Antibiotics Expert Committee ANTIBIOTICS-MICROBIAL ASSAYS AMOXICILLIN INTRAMAMMARY INFUSION AMPHOTERICIN B AMPHOTERICIN B CREAM AMPHOTERICIN B FOR INJECTION AMPHOTERICIN B LOTION AMPHOTERICIN B BACITRACIN BIO4 Antibiotics Expert

More information

Antimicrobial Policy for Adults

Antimicrobial Policy for Adults The Rotherham NHS Foundation Trust Barnsley Hospital NHS Foundation Trust Antimicrobial Policy for Adults Beta-lactams Penicillins Cephalosporins Amoxicillin Cefalexin Benzylpenicillin Cefotaxime Co-amoxiclav

More information

Adult Antibiotic Guidelines. Secondary Care

Adult Antibiotic Guidelines. Secondary Care Adult Antibiotic Guidelines Secondary Care Please note: The Antibiotic Prophylaxis Guideline full document is available on the intranet N.B. Staff should be discouraged from printing this document. This

More information

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER University of Minnesota Health University of Minnesota Medical Center University of Minnesota Masonic Children s Hospital May 2017 Printed herein are

More information

REVOLUTIONARY. MMinimum. BBiofilm EEradication Concentration. inimizing WE HAVE FOUND THE ANSWER.

REVOLUTIONARY. MMinimum. BBiofilm EEradication Concentration. inimizing WE HAVE FOUND THE ANSWER. REVOLUTIONARY. Are recurrent bacterial infections a frustration in your practice? WE HAVE FOUND THE ANSWER. MMinimum inimizing BBiofilm EEradication C oncentration Concentration www.becscreen.com WHY BIOFILM

More information

number Done by Corrected by Doctor Dr Hamed Al-Zoubi

number Done by Corrected by Doctor Dr Hamed Al-Zoubi number 8 Done by Corrected by Doctor Dr Hamed Al-Zoubi 25 10/10/2017 Antibacterial therapy 2 د. حامد الزعبي Dr Hamed Al-Zoubi Antibacterial therapy Figure 2/ Antibiotics target Inhibition of microbial

More information

Measurement of Antimicrobial Drug Use. Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist

Measurement of Antimicrobial Drug Use. Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist Measurement of Antimicrobial Drug Use Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist Defined Daily Dose Target Audience: Administrators and Epidemiologists Standardized definition

More information

Women s Antimicrobial Guidelines Summary

Women s Antimicrobial Guidelines Summary Women s Antimicrobial Guidelines Summary 1. Introduction and Who Guideline applies to This guideline has been developed to deliver safe and appropriate empirical use of antibiotics for patients at University

More information

Liofilchem. ID-AST systems

Liofilchem. ID-AST systems Liofilchem ID-AST systems Systems for ID and AST directly from clinical specimens page 1 Integral Systems for ID and AST from isolated colonies page 4 Systems for ID from isolated colonies page 6 Systems

More information